Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Vitamin D analog EB1089 inhibits aromatase expression by dissociation of comodulator WSTF from the CYP19A1 promoter-a new regulatory pathway for aromatase.

Lundqvist J, Hansen SK, Lykkesfeldt AE.

Biochim Biophys Acta. 2013 Jan;1833(1):40-7. doi: 10.1016/j.bbamcr.2012.10.012. Epub 2012 Oct 18.

2.

Vitamin D-mediated regulation of CYP21A2 transcription - a novel mechanism for vitamin D action.

Lundqvist J, Wikvall K, Norlin M.

Biochim Biophys Acta. 2012 Oct;1820(10):1553-9. doi: 10.1016/j.bbagen.2012.04.017. Epub 2012 Apr 27.

PMID:
22561756
3.

Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D3.

Lundqvist J, Kirkegaard T, Laenkholm AV, Duun-Henriksen AK, Bak M, Feldman D, Lykkesfeldt AE.

J Steroid Biochem Mol Biol. 2017 Jun 10. pii: S0960-0760(17)30154-1. doi: 10.1016/j.jsbmb.2017.06.003. [Epub ahead of print]

PMID:
28610873
4.

Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.

Quack M, Clarin A, Binderup E, Björkling F, Hansen CM, Carlberg C.

J Cell Biochem. 1998 Dec 1;71(3):340-50.

PMID:
9831071
5.

Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.

Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG.

J Cell Physiol. 2001 Sep;188(3):383-93.

PMID:
11473365
6.
7.
8.
9.

The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity.

Nayeri S, Danielsson C, Kahlen JP, Schräder M, Mathiasen IS, Binderup L, Carlberg C.

Oncogene. 1995 Nov 2;11(9):1853-8.

PMID:
7478614
10.

Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy.

Krishnan AV, Swami S, Peng L, Wang J, Moreno J, Feldman D.

Endocrinology. 2010 Jan;151(1):32-42. doi: 10.1210/en.2009-0855. Epub 2009 Nov 11.

11.

Vitamin D analog EB1089 induces apoptosis in a subpopulation of SGC-7901 gastric cancer cells through a mitochondrial-dependent apoptotic pathway.

Wang W, Zhao CH, Zhang N, Wang J.

Nutr Cancer. 2013;65(7):1067-75. doi: 10.1080/01635581.2013.811273. Epub 2013 Oct 7.

PMID:
24099173
12.

Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.

Wietzke JA, Ward EC, Schneider J, Welsh J.

Mol Cell Endocrinol. 2005 Jan 31;230(1-2):59-68.

PMID:
15664452
13.

The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.

Krishnan AV, Swami S, Feldman D.

Steroids. 2012 Sep;77(11):1107-12. doi: 10.1016/j.steroids.2012.06.005. Epub 2012 Jul 16. Review.

14.

Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion.

Flanagan L, Packman K, Juba B, O'Neill S, Tenniswood M, Welsh J.

J Steroid Biochem Mol Biol. 2003 Feb;84(2-3):181-92.

PMID:
12711002
15.

HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.

So JY, Wahler J, Das Gupta S, Salerno DM, Maehr H, Uskokovic M, Suh N.

J Steroid Biochem Mol Biol. 2015 Apr;148:111-21. doi: 10.1016/j.jsbmb.2014.12.013. Epub 2014 Dec 23.

16.

Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo.

Valrance ME, Brunet AH, Welsh J.

Endocrinology. 2007 Oct;148(10):4887-94. Epub 2007 Jul 12.

PMID:
17628009
17.

Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo.

Swami S, Krishnan AV, Wang JY, Jensen K, Peng L, Albertelli MA, Feldman D.

Horm Cancer. 2011 Jun;2(3):190-202. doi: 10.1007/s12672-011-0073-7.

18.

EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.

James SY, Mercer E, Brady M, Binderup L, Colston KW.

Br J Pharmacol. 1998 Nov;125(5):953-62.

19.

Ligand-induced transrepression by VDR through association of WSTF with acetylated histones.

Fujiki R, Kim MS, Sasaki Y, Yoshimura K, Kitagawa H, Kato S.

EMBO J. 2005 Nov 16;24(22):3881-94. Epub 2005 Oct 27. Retraction in: EMBO J. 2014 Dec 1;33(23):2881.

20.

Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity.

Danielsson C, Mathiasen IS, James SY, Nayeri S, Bretting C, Hansen CM, Colston KW, Carlberg C.

J Cell Biochem. 1997 Sep 15;66(4):552-62.

PMID:
9282333

Supplemental Content

Support Center